跳至主要内容
临床试验/NCT01315652
NCT01315652已完成不适用

Evaluation of the Usefulness of a Center Specialized in the Standardized Management of Rheumatoid Arthritis: The COMEDRA Trial

Assistance Publique - Hôpitaux de Paris2 个研究点 分布在 1 个国家目标入组 970 人开始时间: 2011年3月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
970
试验地点
2
主要终点
Comorbidities treatment

研究概览

简要总结

The two objectives of this trial are :1 To evaluate the impact of a visit with a nurse checking the preventive modalities and/or the presence of comorbidities such as infections ( e.g. vaccinations), cardiovascular-diseases (e.g. Indication to statin, antiaggregant,anti-hypertensive treatment…), cancers (e.g.mammography,…), osteoporosis (e.g. bone densitometry,..) in patients suffering from Rheumatoid Arthritis 2 To evaluate the impact of an educational program aimed at permitting rheumatoid arthritis patients to auto-evaluate their disease activity by collecting the Disease Activity Score (DAS28-ESR).

详细描述

Patients with a stable definite Rheumatoid Arthritis will be invited by their rheumatologists to participate at this study in 20 centers in France. After written informed consent will be obtained, the patients will be randomized in two arms:

  • comorbidities
  • auto-DAS The patients will be seen again in the same center six months later in order to collect the outcome measures.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Other
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Rheumatoid Arthritis
  • Stable (no change in therapy)
  • Able to collaborate
  • Exclusion criteria
  • Pregnant woman
  • Change of the therapy for 3 months before the inclusion
  • Alcoholism, toxicomania, psychological problem, sever co morbidity which could invalid the consent or limit the protocol compliance
  • No social coverage affiliate

排除标准

  • 未提供

结局指标

主要结局

Comorbidities treatment

时间窗: 6 months later

Number of actions initiated I order to treat or prevent Rheumatoid Arthritis comorbidities

Auto-DAS: Patient education to calculate his Disease Activity Score

时间窗: 6 months after

Number of patients with a modification in their treatment between baseline and 6 months visits

次要结局

  • Frequency of comorbidities in Rheumatoid Arthritis(6 months later)
  • Adhesion to the current recommendations concerning the prevention of co-morbidities(6 months later)
  • Compliance and satisfaction of the patients concerning the DAS educational program(6 months later)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验